SDH-IN-52
SDH-IN-52 is a succinate dehydrogenase (SDH) inhibitor (IC50 = 0.30 μM) and antifungal agent. SDH-IN-52 inhibits SDH enzyme activity in Rhizoctonia solani, interferes with fungal mitochondrial electron transport, and disrupts mycelial morphology; it exhibits protective and curative effects on rice leaves and is suitable for research related to rice sheath blight and Rhizoctonia solani infection.
For research use only. We do not sell to patients.
- Formula: C22H21ClF2N4O
- Molecular Weight:430.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
SDH 0.30 μM (IC50) |
In Vitro
SDH-IN-52 (compound 6m) (20 μg/mL; seven tested concentrations) exhibits potent antifungal activity against Rhizoctonia solani (EC50 = 0.03 μg/mL) and Sclerotinia sclerotiorum (EC50 = 1.91 μg/mL)[1].
SDH-IN-52 is a potent succinate dehydrogenase (SDH) inhibitor with an IC50 of 0.30 μM[1].
SDH-IN-52 (1 μg/mL) disrupts the normal growth and morphology of Rhizoctonia solani hyphae, causing shrinkage, entanglement, and atrophy[1].
SDH-IN-52 (50 ns) stably binds to the active site of Rhizoctonia solani SDH, forming hydrogen bonds with TYR91 and TRP173, with a binding free energy of -31.7 kcal/mol, and the RMSD remains stable at 0.32 nm within 50 ns[1].
SDH-IN-52 (compound 6m) (50-100 μg/mL; dipping/spraying) exhibits potent in vivo protective and curative efficacy against R. solani on rice leaves, achieving 98.3% protective inhibition and 91.6% curative inhibition at 100 μg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 430.88
-
Formula C22H21ClF2N4O
-
SMILES
O=C(C1=CN(C)N=C1C(F)F)NC2=CC(N(CC3=CC=CC(Cl)=C3)CCC4)=C4C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)